GILEAD SCIENCES, INC. Available-for-sale Securities, Amortized Cost Basis
GILEAD SCIENCES, INC. (GILD) had Available-for-sale Securities, Amortized Cost Basis of $34.76 billion as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-02-27
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $34.76B.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $39.78B.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $35.16B.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $32.24B.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-12-31 | $34.76B 10-K · filed 2018-02-27 | |
| 2017-09-30 | $39.78B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $35.16B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $32.24B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $30.32B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $29.51B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $22.89B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $17.50B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $23.57B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $23.22B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $12.89B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $11.77B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $9.63B 10-K · filed 2016-02-24 | |
| 2013-12-31 | $1.95B 10-K · filed 2015-02-25 | |
| 2012-12-31 | $2.19B 10-K · filed 2013-02-27 | |
| 2012-09-30 | $2.21B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.91B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $569.75M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $9.11B 10-K · filed 2013-02-27 | |
| 2011-09-30 | $4.97B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $4.89B 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $4.93B 10-K · filed 2012-02-23 | $4.41B 10-K · filed 2011-02-28 |
| 2010-09-30 | $4.22B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $2.75B 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $2.66B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |